Back to results
US 7,253,282 B2Granted
Hexafluoroisopropanol substituted cyclohexane derivatives
AssigneeHoffman-La Roche Inc.
InventorsHenrietta Dehmlow, Bernd Kuhn, Raffaello Masciadri, Narendra Panday, Hasane Ratni, Matthew Blake Wright
Life of this patent
Estimating the term…
Abstract
The invention is concerned with novel hexafluoroisopropanol substituted cyclohexane derivatives of formula (I) wherein R1 to R4, X, m and n are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds bind to LXR alpha and LXR beta and can be used as medicaments.
Claims22
A compound of formula (I)
- wherein
- R1 is hydrogen, lower-alkyl, fluoro-lower-alkyl, lower-alkyl-carbonyl, fluoro-lower-alkyl-carbonyl, aryl-lower-alkyl, cycloalkyl-lower-alkyl, cycloalkyl-carbonyl or cycloalkyl-lower-alkyl-carbonyl;
- R2 is hydrogen or lower-alkyl;
- R3 is lower-alkyl, aryl-lower-alkyl, heterocyclyl-lower-alkyl or lower-alkoxy-carbonyl, or, if X is not a single bond, or, if X is a single bond and m is not 0, R3 can also be hydroxy;
- R4 is aryl or heterocyclyl;
- X is a single bond, SO2, CO, C(O)O or C(O)N(R5);
- R5 is hydrogen, lower-alkyl, aryl, heterocyclyl, aryl-lower-alkyl or heterocyclyl-lower-alkyl;
- m is 0, 1, 2 or 3;
- n is 0 or 1;
- and pharmaceutically acceptable salts and esters thereof.
7 more elements
Dependencies are inferred from the claim text.